Sinopharm
1099.HK
#2338
Rank
โ‚น702.65 B
Marketcap
โ‚น225.16
Share price
-0.81%
Change (1 day)
-3.18%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: โ‚น205.52 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.09 Billion. In 2024 the company made an earning of โ‚น205.52 Billion a decrease over its 2023 earnings that were of โ‚น284.90 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024โ‚น205.52 B-27.86%
2023โ‚น284.90 B-0.73%
2022โ‚น287.00 B-1.72%
2021โ‚น292.01 B11.7%
2020โ‚น261.42 B18.44%
2019โ‚น220.71 B10.85%
2018โ‚น199.11 B3.05%
2017โ‚น193.22 B36.48%
2016โ‚น141.57 B7.11%
2015โ‚น132.18 B12.38%
2014โ‚น117.62 B25.05%
2013โ‚น94.06 B22.54%
2012โ‚น76.76 B35.43%
2011โ‚น56.68 B52.24%
2010โ‚น37.23 B30.99%
2009โ‚น28.42 B60.59%
2008โ‚น17.69 B48.29%
2007โ‚น11.93 B123.29%
2006โ‚น5.34 B